TNF Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
EBITDA | -2,188 | -1,825 | -1,861 | -2,784 |
EBIT | -3,722 | -5,569 | ||
Net Income | -2,064 | -1,929 | -9,565 | -9,800 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -764 | -3,631 | -2,668 | -1,912 |
Cash | 173 | 1,192 | 536 | 225 |
Basic Shares | 2,415 | 2,415 | 2,275 | 2,141 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
EBITDA | -4,014 | -3,999 | -15,282 | -29,280 |
EBIT | -6,799 | -17,123 | -30,565 | -29,298 |
Net Income | -23,359 | -3,999 | -15,197 | -29,889 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,976 | -12,980 | -12,270 | -19,516 |
Cash | 173 | 2,681 | 749 | 555 |
Basic Shares | 2,415 | 1,542 | 1,294 | 1,167 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.93 |
2024-09-30 | -$1.10 |
2024-06-30 | -$4.54 |
2024-03-31 | -$5.13 |
